Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018, Article ID 3452739, 7 pages
https://doi.org/10.1155/2018/3452739
Research Article

Identification of Common Genes Refers to Colorectal Carcinogenesis with Paired Cancer and Noncancer Samples

1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China
3Haikou People’s Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan 570311, China
4State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 South Xianlie Road, Guangzhou, Guangdong, China

Correspondence should be addressed to Hong-Hao Zhou; moc.361@3002uohzhh and Zhi-Rong Tan; moc.361@028008natrz

Received 21 June 2017; Accepted 16 October 2017; Published 30 January 2018

Academic Editor: Stamatios E. Theocharis

Copyright © 2018 Lihua Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Wilschut, J. D. F. Habbema, S. D. Ramsey, R. Boer, C. W. N. Looman, and M. van Ballegooijen, “Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis,” Cancer Causes & Control, vol. 21, no. 12, pp. 2287–2293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. E. Schoen, A. Razzak, K. J. Yu et al., “Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer,” Gastroenterology, vol. 149, no. 6, pp. 1438–1445.e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Baars, E. J. Kuipers, M. van Haastert, J. J. Nicolai, A. C. Poen, and C. J. van der Woude, “Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey,” Journal of Gastroenterology, vol. 47, no. 12, pp. 1308–1322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. P. Cleary, M. Cotterchio, E. Shi, S. Gallinger, and P. Harper, “Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk,” American Journal of Epidemiology, vol. 172, no. 9, pp. 1000–1014, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Hurley, D. Goldberg, D. O. Nelson et al., “Risk of colorectal cancer associated with active smoking among female teachers,” Cancer Causes & Control, vol. 24, no. 7, pp. 1291–1304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Liang and A. B. Pardee, “Timeline: analysing differential gene expression in cancer,” Nature Reviews Cancer, vol. 3, no. 11, pp. 869–876, 2003. View at Publisher · View at Google Scholar
  8. R. A. Irizarry, B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed, “Summaries of Affymetrix GeneChip probe level data,” Nucleic Acids Research, vol. 31, no. 4, article e15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Irizarry, B. Hobbs, F. Collin et al., “Exploration, normalization, and summaries of high density oligonucleotide array probe level data,” Biostatistics, vol. 4, no. 2, pp. 249–264, 2003. View at Publisher · View at Google Scholar
  10. Y. X. Shi, T. Zhu, T. Zou et al., “Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma,” Oncotarget, vol. 7, no. 51, pp. 85235–85243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Torto-Alalibo, E. Purwantini, J. Lomax, J. C. Setubal, B. Mukhopadhyay, and B. M. Tyler, “Genetic resources for advanced biofuel production described with the Gene Ontology,” Frontiers in Microbiology, vol. 5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Tilford and N. O. Siemers, “Gene set enrichment analysis,” Methods in Molecular Biology, vol. 563, pp. 99–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. K. Curtis, M. Oresic, and A. Vidal-Puig, “Pathways to the analysis of microarray data,” Trends in Biotechnology, vol. 23, no. 8, pp. 429–435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. B. T. Sherman, D. Huang, Q. Tan et al., “DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis,” BMC Bioinformatics, vol. 8, no. 1, p. 426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. F. Gao, X. Y. Mao, T. Zhu et al., “COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value,” Oncotarget, vol. 7, no. 43, pp. 70494–70503, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Banyai, F. Baidi, D. Coudreuse, and Z. Szilagyi, “Cdk1 activity acts as a quantitative platform for coordinating cell cycle progression with periodic transcription,” Nature Communications, vol. 7, article 11161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Malumbres and M. Barbacid, “Cell cycle, CDKs and cancer: a changing paradigm,” Nature Reviews Cancer, vol. 9, no. 3, pp. 153–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Fang, H. Yu, X. Liang, J. Xu, and X. Cai, “Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer,” Cancer Biology & Therapy, vol. 15, no. 9, pp. 1268–1279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. G. Lu, H. Feng, P. X. Wang, D. P. Han, X. H. Chen, and M. H. Zheng, “Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair,” World Journal of Gastroenterology, vol. 18, no. 34, pp. 4704–4713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Fang, C. Gong, H. Liu et al., “E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2,” Biochemical and Biophysical Research Communications, vol. 464, no. 2, pp. 407–415, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Maiorano, M. Lutzmann, and M. Mechali, “MCM proteins and DNA replication,” Current Opinion in Cell Biology, vol. 18, no. 2, pp. 130–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Giaginis, M. Georgiadou, K. Dimakopoulou et al., “Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity,” Digestive Diseases and Sciences, vol. 54, no. 2, pp. 282–291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Davies, A. Freeman, L. S. Morris et al., “Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool,” Lancet, vol. 359, no. 9321, pp. 1917–1919, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Chon, A. Vassilev, M. L. DePamphilis et al., “Contributions of the two accessory subunits, RNASEH2B and RNASEH2C, to the activity and properties of the human RNase H2 complex,” Nucleic Acids Research, vol. 37, no. 1, pp. 96–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Yang, H. Y. Huang, Y. S. Chang, C. L. Lin, I. L. Lai, and J. G. Chang, “DNA-sensing and nuclease gene expressions as markers for colorectal cancer progression,” Oncology, vol. 92, no. 2, pp. 115–124, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Chen, Y. Sun, P. Ji, S. Kopetz, and W. Zhang, “Topoisomerase IIα in chromosome instability and personalized cancer therapy,” Oncogene, vol. 34, no. 31, pp. 4019–4031, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Bofin, B. Ytterhus, and B. M. Hagmar, “TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas,” Cytopathology, vol. 14, no. 6, pp. 314–319, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Simon, R. Atefy, U. Wagner et al., “HER-2 and TOP2A gene amplification in urinary bladder cancer,” Verhandlungen der Deutschen Gesellschaft für Pathologie, vol. 86, pp. 176–183, 2002. View at Google Scholar
  29. I. M. H. Sønderstrup, S. B. Nygård, T. S. Poulsen et al., “Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers,” Molecular Oncology, vol. 9, no. 6, pp. 1207–1217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Coss, M. Tosetto, E. J. Fox et al., “Increased topoisomerase IIα expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis,” Cancer Letters, vol. 276, no. 2, pp. 228–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Tsuji, C. Kamagata, M. Furuya et al., “Selection of an internal control gene for quantitation of mRNA in colonic tissues,” Anticancer Research, vol. 22, no. 6C, pp. 4173–4178, 2002. View at Google Scholar
  32. E. Sagynaliev, R. Steinert, G. Nestler, H. Lippert, M. Knoch, and M. A. Reymond, “Web-based data warehouse on gene expression in human colorectal cancer,” Proteomics, vol. 5, no. 12, pp. 3066–3078, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. E. A. H. Kheirelseid, K. Chang, J. Newell, M. J. Kerin, and N. Miller, “Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer,” BMC Molecular Biology, vol. 11, no. 1, p. 12, 2010. View at Publisher · View at Google Scholar · View at Scopus